Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMRT Chemoradiation for Locally Advanced Esophageal Cancer
ChiCTR-OIC-17010485Phase 2Completed
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and fluorouracil in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Fudan University Shanghai Cancer Center. Primary endpoints: Local control rate and Number of participants with adverse events. Started Feb 2012; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on ChiCTR-OIC-17010485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIC-17010485.